132 related articles for article (PubMed ID: 22767590)
1. Protein kinase casein kinase 2-mediated upregulation of N-cadherin confers anoikis resistance on esophageal carcinoma cells.
Ko H; Kim S; Jin CH; Lee E; Ham S; Yook JI; Kim K
Mol Cancer Res; 2012 Aug; 10(8):1032-8. PubMed ID: 22767590
[TBL] [Abstract][Full Text] [Related]
2. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
3. Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.
Jin CH; Jun KY; Lee E; Kim S; Kwon Y; Kim K; Na Y
Bioorg Med Chem; 2014 Sep; 22(17):4553-65. PubMed ID: 25131958
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
Kang HG; Jenabi JM; Zhang J; Keshelava N; Shimada H; May WA; Ng T; Reynolds CP; Triche TJ; Sorensen PH
Cancer Res; 2007 Apr; 67(7):3094-105. PubMed ID: 17409416
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma.
Li K; He W; Lin N; Wang X; Fan QX
Cancer Invest; 2010 Jun; 28(5):479-86. PubMed ID: 20014942
[TBL] [Abstract][Full Text] [Related]
7. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
[TBL] [Abstract][Full Text] [Related]
9. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
Ravid D; Maor S; Werner H; Liscovitch M
Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
[TBL] [Abstract][Full Text] [Related]
11. N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
Yoshinaga K; Inoue H; Utsunomiya T; Sonoda H; Masuda T; Mimori K; Tanaka Y; Mori M
Clin Cancer Res; 2004 Sep; 10(17):5702-7. PubMed ID: 15355896
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
13. Delayed caspase-8 activation and enhanced integrin β1-activated FAK underpins anoikis in oesophageal carcinoma cells harbouring mt p53-R175H.
Fanucchi S; Veale RB
Cell Biol Int; 2011 Aug; 35(8):819-26. PubMed ID: 21426305
[TBL] [Abstract][Full Text] [Related]
14. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
[TBL] [Abstract][Full Text] [Related]
15. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.
Derouet MF; Liu G; Darling GE
PLoS One; 2014; 9(12):e115589. PubMed ID: 25551563
[TBL] [Abstract][Full Text] [Related]
16. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src.
Sakuma Y; Takeuchi T; Nakamura Y; Yoshihara M; Matsukuma S; Nakayama H; Ohgane N; Yokose T; Kameda Y; Tsuchiya E; Miyagi Y
J Pathol; 2010 Apr; 220(5):574-85. PubMed ID: 20146241
[TBL] [Abstract][Full Text] [Related]
17. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
18. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
[TBL] [Abstract][Full Text] [Related]
19. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
Kamarajan P; Kapila YL
Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
[TBL] [Abstract][Full Text] [Related]
20. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
Galante JM; Mortenson MM; Bowles TL; Virudachalam S; Bold RJ
J Surg Res; 2009 Mar; 152(1):18-25. PubMed ID: 19062038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
